SREBP2 and SREBP2-dependent cholesterol biosynthesis are activated by c-Met/PI3K/AKT/mTOR axis in CRC, which allows CRC cells to undergo dynamic metabolic adjustments, facilitating adaptation to metastatic conditions (Zhang K. L. et al., 2021). This evidence concerns the gene MET and colorectal carcinoma.